The article discusses the diagnosis and treatment of men infected with hepatitis C virus (HCV). The importance of HCV testing and treatment is discussed. The findings of two studies published in the April 24, 2014 issue of "New England Journal of Medicine" on the two oral drugs for treating...
“This research is the first to demonstrate the antiviral activity of Fluvastatin in human beings infected with hepatitis C, most of whom were non-responders to the standard of care treatment,” said Ted Bader, M.D., the principle investigator on the project and the director of liver diseases...
Ornstein C. New hepatitis C drugs are costing Medicare billions. The Washington Post; 2015. https://www.washingtonpost.com/national/ health-science/medicare-spent-45-billion-on-new-hepatitis-c-drugs-last- year-data-shows/2015/03/29/66952dde-d32a-11e4-a62f-ee745911a4ff_ story.html. ...
Hepatitis C affects >3 million people in the United States, and often leads to end-stage liver disease or death. In 2014, several new drugs to treat hepatitic C virus received US Food and Drug Administration approval, with remarkable cure rates exceeding 90%. Medicaid, however, is rationing...
A study led by Boston Medical Center (BMC) researchers demonstrates that while new therapies to treat Hepatitis C Virus (HCV) are highly effective, they are cost-effective and provide the greatest value in specific groups of HCV-infected patients. The fi
Hepatitis C - New drugs and treatment prospects Hepatitis C virus (HCV) affects approx. 3% of the world's population and accounts for ca 300000 deaths per year. 80% of individuals with HCV develop chroni... M Zajc,I Muszalska,A Sobczak,... - 《European Journal of Medicinal Chemistry》...
Drugs for hepatitis C: Unlocking a new mechanism of action. ChemMedChem. 2010.5 (10): 1663-65Bell, T.W. Drugs for hepatitis C: Unlocking a new mechanism of action. ChemMedChem 2010, 5, 1663-1665. [CrossRef] [PubMed]Bell TW. Drugs for hepatitis C: unlocking a new mechanism of ac- ...
Soriano V;Labarga P;Barreiro P;.Drug interactions with new hepatitis C oral drugs.Expert Opin Drug Metab Toxicol.2015.333-341Soriano V, Labarga P, Barreiro P, et al. Drug interactions with new hepatitis C oral drugs. Expert Opin Drug Metab Toxicol. 2015;11: 333-41....
About 130-170 million people, is estimated to be infected with the hepatitis C virus(HCV). Chronic HCV infection is one of the leading causes of liverrelated death and in many countries it is the primaryreason for having a liver transplant. The main aim of antiviral treatment is to ...
In the last three weeks, the Food and Drug Administration has approved two new drugs that are expected to dramatically improve treatment of chronic hepatitis C, a liver-damaging viral infection that afflicts more than 3.2 million Americans. ...